- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Dea
Recent news which mentions Dea
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
May 01, 2024
From Benzinga
DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses
May 01, 2024
From Benzinga
From Benzinga
Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
April 30, 2024
From Benzinga
Rep Blumenauer On Marijuana Reclassification: 'Legalization Is Inevitable, Biden-Harris Admin Is Listening' To The People
April 30, 2024
From Benzinga
DEA's Move To Reclassify Cannabis Seen As 'Significant,' But Fails To Resolve State-Federal Conflict
April 30, 2024
Tickers
DEA
From Benzinga
From Benzinga
US Cannabis Council Call DEA Historic Decision To Reclassify Cannabis 'A Tectonic Shift'
April 30, 2024
Tickers
DEA
From Benzinga
Breaking: DEA Reportedly Moves To Reschedule Cannabis, Stocks Rise Sharply On The News
April 30, 2024
From Benzinga
Tickers
DEA
From InvestorPlace
Senators Warren, Fetterman Plus 18 More Dems Tell DEA 'It's Time To Act' On Cannabis Rescheduling
April 25, 2024
From Benzinga
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
April 24, 2024
From Benzinga
DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
April 19, 2024
From Benzinga
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
April 12, 2024
From Benzinga
FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling
April 12, 2024
From Benzinga
Why Real Estate Stocks Were Hurting Today
April 10, 2024
From Motley Fool
'This Is Insanity, Someone's Got To Act,' Marijuana Researcher Files Fed Lawsuit Against DEA Over 'Unconstitutional Process'
April 10, 2024
From Benzinga
These Top REITs Have Yields Up to 9.1%
April 09, 2024
From Benzinga
EXCLUSIVE: DEA-Licensed Cannabis Co. Maridose To Launch Series A Funding Round At Upcoming Benzinga Conference
April 05, 2024
From Benzinga
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
April 02, 2024
From Benzinga
From Benzinga
DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'
March 28, 2024
From Benzinga
GOP Mitt Romney Pens Letter To DEA Bashing Cannabis Rescheduling, Dems' Letter To DOJ Bashes Broken Promises
March 27, 2024
From Benzinga
Rep. Blumenauer Grills Fed Health Agency For Clarity On Cannabis Rescheduling As Debate Heats Up
March 21, 2024
From Benzinga
From Benzinga
VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
March 15, 2024
From Benzinga
From Benzinga
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
March 14, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.